Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dekavil in Active Rheumatoid Arthritis
NCT02270632Phase 2Terminated
- Sponsor
- Philogen
- Start
- Oct 2014
- Primary completion
- Apr 2019
- Modality
- Antibody Conjugates, Cytokines & Interferons, Engineered Antibody Formats
- Countries
- 3
01
Overview
A Phase 2 trial of f8il10 in rheumatoid arthritis (RA), sponsored by Philogen. Started Oct 2014; status: terminated.
02
Drugs
f8il10
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02270632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270632.